Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Applied DNA Sciences (APDN) Terminates Equity Distribution Agreement
-
Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference
-
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
-
Applied DNA to Participate in Upcoming Conferences
-
Applied DNA Sciences (APDN) PT Raised to $18 at Maxim Group, Following Earnings
-
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
-
Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
-
Maxim Group Upgrades Applied DNA Sciences (APDN) to Buy
-
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering
-
Applied DNA Sciences (APDN) to Offer 2.285M Shares with Warrants at $5.25
-
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering
-
Applied DNA Reports Fiscal First Quarter 2019 Financial Results
-
Maxim Group Downgrades Applied DNA Sciences (APDN) to Hold
-
Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants
-
Applied DNA Sciences (APDN) Prices 5.5M Share/Warrant Offering at $0.50/Unit
-
Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants
-
Applied DNA Sciences (APDN) Plans Public Offering of Common Stock and Warrants
-
Applied DNA Announces Proposed Public Offering of Common Stock and Warrants
-
Applied DNA Sciences (APDN) PT Lowered to $3 at Maxim Group
-
Maxim Group Assumes Applied DNA Sciences (APDN) at Buy
-
Applied DNA Sciences (APDN) Prices 2.735M Share Common Offering at $1.75/Sh
-
Applied DNA Announces $4.8 Million Registered Direct Offering of Common Stock
-
Applied DNA Sciences Closes on $5 Million Private Placement
-
Applied DNA Sciences Announces $5 Million Private Placement
-
Applied DNA Sciences (APDN) Closes 2.5M Share Registered Direct Offering
-
Applied DNA Sciences Announces Closing of $8.75 Million Registered Direct Offering
-
Applied DNA Sciences Announces $8.75 Million Registered Direct Offering
-
Applied DNA Sciences (APDN) Enters Common Stock, Warrants Direct Placement
-
Applied DNA Sciences (APDN) Buy Rating Maintained at Maxim Group
-
Applied DNA Sciences' (APDN) Price Target Raised to $13 at Maxim Group
-
Applied DNA Sciences, Inc. Announces Closing of $12.0 Million Public Offering and Partial Exercise of Over-Allotment Option
-
Applied DNA Sciences (APDN) Prices 3.82M Share Common/Warrant Offering at $3
-
Applied DNA Sciences (APDN) Prices $11.46M Offering of Stock and Warrants
-
Applied DNA Sciences Prices $11.46 Million Public Offering
-
Applied DNA Sciences (APDN) Plans Common, Warrants Offering
-
Applied DNA Sciences Announces Proposed Public Offering
-
Maxim Group Starts Applied DNA Sciences (APDN) at Buy
-
Applied DNA Sciences (APDN) Closes 2.8M Common, Warrants Offering

